[{"id":"14038a3a-bab1-4431-b313-a721b6553a56","acronym":"","url":"https://clinicaltrials.gov/study/NCT06116240","created_at":"2023-11-03T20:12:26.687Z","updated_at":"2024-07-02T16:35:30.413Z","phase":"Phase 1","brief_title":"A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT06116240","lead_sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • pemetrexed • Andewei (benmelstobart) • AL2846"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 135","initiation":"Initiation: 09/02/2022","start_date":" 09/02/2022","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2023-11-03"},{"id":"0999bd9c-b44a-412c-8986-522b58c74f3b","acronym":"","url":"https://clinicaltrials.gov/study/NCT04325776","created_at":"2021-01-18T20:57:17.503Z","updated_at":"2024-07-02T16:36:40.172Z","phase":"Phase 2","brief_title":"A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis","source_id_and_acronym":"NCT04325776","lead_sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","biomarkers":" EGFR • ALK • MET • KIT • FGFR","pipe":"","alterations":" ","tags":["EGFR • ALK • MET • KIT • FGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e zoledronic acid • AL2846"],"overall_status":"Unknown status","enrollment":" Enrollment 60","initiation":"Initiation: 09/24/2020","start_date":" 09/24/2020","primary_txt":" Primary completion: 05/01/2021","primary_completion_date":" 05/01/2021","study_txt":" Completion: 11/01/2021","study_completion_date":" 11/01/2021","last_update_posted":"2020-10-12"}]